Referenslitteratur
för:
Tea Tree Oil |
|
| |
FÖRFATTARE
OCH TIDSKRIFT |
PUBLICERAD |
HÄMTA
PDF |
| |
|
|
|
| |
1.
Saller R, Berger T, Harkenthal M.
Pharmaceutical and medicinal aspects of australian tea tree oil.
Phytomedicine 5(6):489-95; 1998.
|
1998 |
|
|
|
2. Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH:
Tea tre oil reduces histamine-induced skin inflammation.
Br J Dermatol 147: 1212-17; 2002.
|
2002
|
|
|
|
3. Abe s, Maruyama N, Hayama K, Ishibashi H, Inoue S, Oshima H, Yamaguchi H:
Supression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils.
Mediators of Inflammation 12: 323-8; 2003.
|
2003 |
|
|
|
4. Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A:
In vitro and in vivo activity of tea tree oils against azole-susceptible and -resistant human pathogenic yeasts.
J Antimicrobial Chemotherapy 2003.
|
2003
|
|
|
|
5. Messager S, Hammer KA, Carson CF, Riely TV:
Assessment of the antibacterial activity of tea tree oil using the European EN 1276 and EN 12054 standard suspension tests.
Journal of Hospital Infection XX: 1-13; 2004.
|
2004
|
|
| |
6. Calcabrini A, Stringaro A, Toccacieli L, et al.:
Terpinen-4-ol, The Main Component of Melaleuca Alternifolia (Tea Tree) Oil Inhibits the In Vitro Growth of Human Melanoma Cells.
J Invest Dermatol 122: 349-60; 2004.
|
2004
|
|
| |
7. Benger S, Townsend P, Ashford RL, Lambert P:
An in vitro study to determine the minimum inhibitory concentration of Melaleuca alternifolia against the dermatophyte Trichophyton rubrum.
The Foot 14: 86-91; 2004.
|
2004
|
|
| |
8. Messager S, Hammer KA, Carson CF, Riley TV:
Effectiveness of hand-cleansing formulations containing tea tree oil assessed ex vivo on human skin and in vivo with volunteers using European standard EN 1499.
Journal of Hospital Infection XX: 1-9; 2004.
|
2004
|
|
| |
|
|
|
|